The improving environment for deals is encouraging some smaller firms to start hunting much larger prey.Most Read from ...
Goldman Sachs analyst Matthew Sykes double downgraded Cytek Biosciences (CTKB) to Sell from Buy with a price target of $4.50, down from $7. The ...
In a regulatory filing, Adobe (ADBE) disclosed that on January 24, Scott Belsky notified the company of his decision to resign as Chief ...
It looks like you're using an old browser. To access all of the content on Yr, we recommend that you update your browser. It looks like JavaScript is disabled in your browser. To access all the ...